Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Gentex Corp Market Cap
From what 11 stock analysts predict, the share price for Gentex Corp (GNTX) might increase by 11.83% in the next year. This is based on a 12-month average estimation for GNTX. Price targets go from $30 to $38.2. The majority of stock analysts believe GNTX is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 11 Wall Street analysts have assigned GNTX 6 buy ratings, 5 hold ratings, and 0 sell ratings. This means that analysts expect Gentex Corp to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on GNTX. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of GNTX.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Ronald Jewsikow Guggenheim | Buy | $34 | Maintains | Nov 21, 2024 |
| David Leiker Baird | Outperform | $37 | Maintains | Oct 28, 2024 |
| John Murphy B of A Securities | Neutral | $35 | Maintains | Oct 14, 2024 |
| Mark Delaney Goldman Sachs | Neutral | $31 | Maintains | Oct 1, 2024 |
| Joseph Spak UBS | Neutral | $34 | Initiates | Sep 4, 2024 |
| Josh Nichols B. Riley Securities | Buy | $41 | Maintains | Jul 29, 2024 |
| David Leiker Baird | Outperform | $38 | Maintains | Jul 29, 2024 |
| Ryan Brinkman JP Morgan | Neutral | $35 | Maintains | Jul 22, 2024 |
| David Leiker Baird | Outperform | $40 | Maintains | Jul 12, 2024 |
| Ronald Jewsikow Guggenheim | Buy | $41 | Maintains | Apr 17, 2024 |
| Josh Nichols B. Riley Securities | Buy | $44 | Maintains | Mar 20, 2024 |
| Ronald Jewsikow Guggenheim | Buy | $40 | Maintains | Mar 19, 2024 |
| Mark Delaney Goldman Sachs | Neutral | $35 | Maintains | Jan 29, 2024 |
| Josh Nichols B. Riley Securities | Buy | $42 | Maintains | Jan 29, 2024 |
| Ryan Brinkman JP Morgan | Neutral | $37 | Maintains | Jan 25, 2024 |
| Josh Nichols B. Riley Securities | Buy | $40 | Maintains | Jul 31, 2023 |
| David Leiker Baird | Outperform | $37 | Maintains | Jul 31, 2023 |
| Mark Delaney Goldman Sachs | Neutral | $33 | Maintains | Jul 31, 2023 |
| Ryan Brinkman JP Morgan | Neutral | $30 | Maintains | Jul 20, 2023 |
| Josh Nichols B. Riley Securities | Buy | $35 | Reinstates | Jul 19, 2023 |
When did it IPO
1990
Staff Count
6,245
Country
United States
Sector/Industry
Consumer Cyclical/Auto Parts
CEO
Mr. Steven R. Downing
Market Cap
$7.08B
In 2023, GNTX generated $2.30B in revenue, which was a increase of 19.82% from the previous year. This can be seen as a signal that GNTX's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Tue, 03 Dec 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - PhotoniCare Inc. has raised $4.6 million in Series B financing and partnered with Gentex Corporation for its FDA-cleared OtoSight™ Middle Ear Scope. The company has relocated its headquarters to Grand Rapids, MI.
Why It Matters - PhotoniCare's $4.6 million funding, manufacturing partnership, and headquarters relocation signal growth potential, innovation in healthcare, and strategic positioning, which could enhance investor confidence and stock value.
Tue, 26 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Gentex Corporation (NASDAQ: GNTX) declared a quarterly cash dividend of $0.12 per share, payable on January 22, 2025, to shareholders of record as of January 8, 2025.
Why It Matters - Gentex Corporation's dividend announcement signals financial stability and commitment to returning value to shareholders, potentially attracting income-focused investors and boosting stock demand.
Tue, 26 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Gentex Corporation has received an Other Transaction Agreement from the U.S. Navy for the Next Generation Fixed Wing Helmet program, enhancing its role in military protection solutions.
Why It Matters - Gentex's OTA with the U.S. Navy for the NGFWH program enhances its market position, indicating potential revenue growth and increased demand for its defense technologies.
Tue, 05 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Gentex Corporation (NASDAQ: GNTX) is showcasing new custom vehicle builds at the SEMA Show in Las Vegas, highlighting its automotive technology portfolio, including connectivity and dimmable glass products.
Why It Matters - Gentex Corporation's showcase at the SEMA Show highlights its innovation in automotive technology, potentially boosting its market position and attracting investor interest.
Fri, 01 Nov 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Gentex Corporation has secured a contract with the U.S. Air Force to develop and supply over 13,000 Block III Night Spectacles for aircrew laser protection.
Why It Matters - Gentex's contract with the U.S. Air Force for laser protective eyewear signals strong demand for its products, potentially boosting revenue and investor confidence in the company's growth prospects.
Mon, 28 Oct 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - GNTX reported mixed Q3 results and revised its 2024 net sales forecast to $2.35-$2.40 billion, down from $2.40-$2.50 billion.
Why It Matters - GNTX's lowered sales guidance signals potential revenue challenges, impacting investor confidence and possibly affecting stock performance. Mixed results may raise concerns about future growth.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
